Profile Information
- Affiliation
- Radiology Division Theragnostics Centre, Fujita Health University Hospital
- ORCID ID
https://orcid.org/0009-0008-0980-1767- researchmap Member ID
- B000230480
Specializing in in-house production of radiopharmaceuticals, quality control, and system-level workflow design, he focuses on optimizing the entire operational framework of radiopharmaceutical practice, including PET tracer synthesis, QC, supply management, and education systems.
In recent years, his work has emphasized the development of sustainable operational systems in clinical settings by integrating troubleshooting experiences and practical knowledge into structured workflows and educational resources.
After graduating from the Faculty of Engineering at Tottori University, he pursued graduate studies in material and biological informatics at the Graduate School of Human Informatics, Nagoya University. He subsequently engaged in research and technical development in both industry and research institutions, including the National Institute of Advanced Industrial Science and Technology (AIST), the National Center for Geriatrics and Gerontology, and Nagoya University, and obtained a doctoral degree in protein chemistry. He is currently involved in the production and operational management of radiopharmaceuticals at Fujita Health University Hospital.
Papers
14-
RADIOISOTOPES, 75(3) 1-8, Nov 15, 2026 Peer-reviewedLead authorLast authorCorresponding author
-
Nuclear Medicine Communications, 47(11), Nov, 2026 Peer-reviewedLead authorCorresponding authorAccepted for publication in Nuclear Medicine Communications (June 2026). Co-first authors: Masanori Watanabe and Hiroshi Yamaguchi.
-
Radiochimica Acta, Oct 26, 2026 Peer-reviewedLead authorCorresponding author2026年8月25日 受理(Accepted)
-
Nuclear Medicine Communications, Oct 13, 2026 Peer-reviewedLead authorLast authorCorresponding authorPurpose The study aimed to develop and evaluate a practical model for determining cyclotron irradiation time based on planned fluorodeoxyglucose (FDG) supply in a hospital-based production setting. Methods Irradiation time was calculated using a composite coefficient of 2.8 min per GBq of planned clinical demand. The coefficient integrated a facility-specific conversion between required end-of-bombardment activity and irradiation time, a conservative synthesis yield of 55%, quality control activity consumption of 11.1%, radioactive decay during an approximately 30-min processing interval, and an operational safety factor of 1.2. Results During a fixed 24-month evaluation period, the model was applied on 516 consecutive scheduled FDG production days. Sufficient FDG activity was supplied for all scheduled examinations on all 516 days (100%), with no activity shortage attributable to underestimation of the required irradiation time. Conclusion A demand-based irradiation model incorporating conservative yield assumptions, quality control consumption, and handling margins enables reliable FDG supply while maintaining an appropriate activity margin. This approach provides a practical framework for hospital-based radiopharmaceutical production.
-
Health Physics, Oct 8, 2026 Peer-reviewedLead authorCorresponding authorAccepted for publication in Operational Radiation Safety, a quarterly supplement of Health Physics (25 Aug 2026).
-
Nuclear Medicine Communications, 47(10) 1218-1219, Oct, 2026 Lead authorLast authorCorresponding author
-
74(10), Oct, 2026 Peer-reviewedLast authorCorresponding author
-
Nuclear Medicine Communications, Jul 28, 2026 Peer-reviewedLead authorLast authorCorresponding authorThis technical note reports threshold behavior of droplet release in automated [¹⁸F]FDG quality control. During routine operation of an automated QC system, small-volume dispensing showed unstable droplet release, resulting in misplacement on test media. Droplet behavior was sensitive to programmed dispensing volume: 0.011 mL frequently resulted in adhesion to the needle tip, 0.012 mL showed borderline behavior, and 0.013 mL restored stable release. The findings highlight the importance of periodic verification and adaptive adjustment of dispensing parameters in automated radiopharmaceutical quality control.
-
Journal of Nuclear Medicine Technology, Jul 21, 2026 Peer-reviewedLead authorLast authorCorresponding authorRoutine maintenance of a radio-HPLC detector system resulted in an unintended shift of the detector energy window from 511 keV to approximately 400 keV, causing substantial signal attenuation during radiopharmaceutical quality control. This report describes the incident, root cause analysis, and the role of technologists and site engineers in identifying and resolving the problem.
-
Journal of Nuclear Medicine Technology, Jun 23, 2026 Peer-reviewedLead authorCorresponding author
-
Applied Radiation and Isotopes, 231 112496-112496, May, 2026 Peer-reviewedLead authorLast authorCorresponding author
-
Applied Radiation and Isotopes, 112563-112563, Mar 21, 2026 Peer-reviewedLead authorLast authorCorresponding author
-
Journal of Nuclear Medicine Technology, 54(1), Feb 10, 2026 Peer-reviewedLead authorLast authorCorresponding author
-
Journal of Clinical Engineering, In press, 2026 Peer-reviewedLead authorLast authorCorresponding authorAccepted for publication in the October–December 2026 issue of the Journal of Clinical Engineering.
Major Misc.
8-
Operational Protocol for Sustainable FDG Production in Hospital-Based Radiopharmaceutical FacilitiesUnpublished Technical Report (Institutional Document), Apr, 2026 Lead authorLast authorCorresponding authorThis report presents a structured operational protocol for sustainable 18F-FDG production in hospital-based radiopharmaceutical facilities. The protocol integrates routine workflow, troubleshooting processes, and education-driven system design to ensure stable and safe production. Rather than treating operational issues as isolated events, this framework systematically converts troubleshooting experiences into standardized workflows and training resources. This approach enables continuous system improvement and transforms operational variability into structured system resilience in radiopharmaceutical practice.